Clinic Events Radiation Oncology 
Imaging Technology
MAY 6, 2024
This strategic move bolsters Elekta’s position in treatment planning and underscores its commitment to being the innovation leader in radiation therapy. Martijn Hartjes , Business Leader Clinical Informatics at Philips, added: “We are pleased that we can continue to support our customers with leading solutions in radiation oncology.
AuntMinnie
SEPTEMBER 30, 2024
A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. The researchers also tracked overall survival and rates of adverse events.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
APRIL 29, 2024
a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center , aims to demonstrate the feasibility of PGHD collection during proton beam radiotherapy for lung cancer. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.
AuntMinnie
JULY 12, 2024
Beyder, along with Vikas Prasad, MD, PhD, and BJH/WU Radiation Oncology all played an integral role in launching the SNMMI radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, Barnes-Jewish Hospital, and Siteman Cancer Center last year. Involve radiation safety early in your therapy center development.
Imaging Technology
SEPTEMBER 13, 2023
associate professor of Radiation Oncology. “IMRT spared more normal tissue than 3D-CRT, which translated into a clinically meaningful benefit to patients,” Chun said. The findings were presented today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer by Stephen Chun, M.D.,
Imaging Technology
SEPTEMBER 27, 2023
milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.
Imaging Technology
SEPTEMBER 27, 2023
PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. Clinical correlation, which may include histopathological evaluation, is recommended.
Expert insights. Personalized for you.
111 
Let's personalize your content